Sante Ventures

Santé Ventures is a healthcare and life science venture capital firm that invests exclusively in early-stage companies developing new medical technologies or healthcare delivery models. The firm, which is based in Austin, Texas, was founded in 2006 and has $132 million in capital under management in its debut fund.

Team

• Kevin Lalande, Managing Director
• Joe Cunningham, MD, Managing Director
• Doug French, Managing Director
• Casey Cunningham, MD, Chief Scientific Officer
• Omar Khalil, Senior Associate
• Jim Graham, Senior Associate
• Alfred Macdaniel, VP of Finance and General Counsel
• Joel Lang, Research and Analytics
• Jenny Murphy, Director of Communications

Portfolio Companies

• BioStable located in Austin, Texas, specializes in technologies to treat heart valve disease.
• Molecular Templates is a biopharmaceutical company with a novel protein platform for the development of new therapeutics against cancer.
• Protein Discovery is a life science company that provides products that simplify and accelerate the preparation of complex biological samples for analysis by mass spectrometry.
• Spinal Restoration is focused on a new, early intervention, minimally invasive treatment with clinically proven results that addresses needs in spine health management.
• Zeno Corporation Established in Houston, Texas, in September 2002, Zeno Corporation, formerly Tyrell, Inc., is the leading pioneer in the category of personal medical devices. The company was formed to develop and launch Zeno, a product set to revolutionize over-the-counter treatment of acne pimples. Using proprietary ClearPoint technology, Zeno electronic medical devices apply sustained heat therapy to destroy the bacteria that cause common acne, dramatically reducing the healing time of pimples. The Zeno acne product line includes Zeno MD, Zeno PRO, Zeno and Zeno Mini.
• Hospitalists Now is a full service physician group practice, management and consulting company, providing hospitalist services. The Austin-based company supplies and coordinates inpatient care for its contracted client hospitals in partnership with local primary care physicians and specialists.
• Terapio is a biopharmaceutical company specializing in the development of a pipeline of therapies based on the transport protein, RLIP76.
• TVA Medicalis a medical device company developing innovative, minimally invasive therapies for treatment of End-Stage Renal Disease(ESRD).

References

• Santé invests in Austin biomedical startup TVA Medical. Austin American-Statesman, January 10, 2010
• Austin-based Biotech Startup Gets $5 million. Austin American-Statesman, November 30, 2009
• Terapio Collects $5M from Sante. Austin Business Journal, November 30, 2009
• New Texas Cancer Institute Plans High-Impact Research. Fort Worth Business Press, August 31, 2009
• Sante Sees Real Opportunity in Austin Companys Future. [[Austin American-Statesman]], June 2, 2009
• Up the Ladder. Austin American-Statesman, May 20, 2009
• Biotech Company Raises 2.5 Million. Austin American-Statesman, April 10, 2009

External links

• Santé Ventures (company website)